Release Date: 31/07/20 13:44 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 3.43MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%